| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 19.32% | Morgan Stanley | $100 → $90 | Maintains | Equal-Weight |
| 11/06/2023 | 48.48% | Barclays | $138 → $112 | Maintains | Overweight |
| 11/03/2023 | 49.81% | RBC Capital | $130 → $113 | Maintains | Outperform |
| 11/03/2023 | 6.06% | Piper Sandler | $82 → $80 | Upgrades | Underweight → Neutral |
| 10/19/2023 | 92.23% | JP Morgan | → $145 | Upgrades | Neutral → Overweight |
| 10/11/2023 | 106.81% | Citigroup | $162 → $156 | Maintains | Buy |
| 10/10/2023 | 86.93% | UBS | $143 → $141 | Maintains | Buy |
| 10/09/2023 | 97.53% | Oppenheimer | → $149 | Reiterates | Outperform → Outperform |
| 10/03/2023 | 40.53% | Wells Fargo | $112 → $106 | Maintains | Equal-Weight |
| 09/13/2023 | 89.58% | UBS | → $143 | Initiates Coverage On | → Buy |
| 08/08/2023 | 63.07% | JP Morgan | $120 → $123 | Maintains | Neutral |
| 08/07/2023 | 82.95% | Barclays | $135 → $138 | Maintains | Overweight |
| 08/04/2023 | 97.53% | Oppenheimer | $146 → $149 | Maintains | Outperform |
| 08/04/2023 | 48.48% | Wells Fargo | $108 → $112 | Maintains | Equal-Weight |
| 08/04/2023 | 72.35% | RBC Capital | $127 → $130 | Maintains | Outperform |
| 07/18/2023 | 105.49% | Citigroup | $150 → $155 | Maintains | Buy |
| 07/10/2023 | 43.18% | Wells Fargo | $100 → $108 | Maintains | Equal-Weight |
| 07/06/2023 | 85.6% | B of A Securities | $130 → $140 | Upgrades | Neutral → Buy |
| 06/08/2023 | 72.35% | Wolfe Research | → $130 | Upgrades | Peer Perform → Outperform |
| 05/17/2023 | 82.95% | Guggenheim | $152 → $138 | Maintains | Buy |
| 05/16/2023 | 32.57% | Morgan Stanley | $105 → $100 | Maintains | Equal-Weight |
| 05/08/2023 | 78.97% | Barclays | $142 → $135 | Maintains | Overweight |
| 05/05/2023 | 98.86% | Citigroup | $154 → $150 | Maintains | Buy |
| 05/05/2023 | 68.37% | RBC Capital | $128 → $127 | Maintains | Outperform |
| 05/05/2023 | 65.72% | Raymond James | $135 → $125 | Maintains | Outperform |
| 05/05/2023 | 32.57% | Wells Fargo | $113 → $100 | Maintains | Equal-Weight |
| 05/05/2023 | 78.97% | Baird | $141 → $135 | Maintains | Outperform |
| 04/17/2023 | 88.25% | Barclays | $150 → $142 | Maintains | Overweight |
| 04/10/2023 | 49.81% | Wells Fargo | $120 → $113 | Maintains | Equal-Weight |
| 03/20/2023 | 69.69% | RBC Capital | → $128 | Reiterates | → Outperform |
| 02/15/2023 | 90.91% | Cowen & Co. | $134 → $144 | Maintains | Outperform |
| 02/15/2023 | 101.51% | Guggenheim | $138 → $152 | Maintains | Buy |
| 02/15/2023 | 104.16% | Citigroup | $138 → $154 | Maintains | Buy |
| 02/15/2023 | 59.09% | Wells Fargo | $115 → $120 | Maintains | Equal-Weight |
| 02/15/2023 | 69.69% | RBC Capital | $126 → $128 | Maintains | Outperform |
| 02/15/2023 | 86.93% | Baird | $135 → $141 | Maintains | Outperform |
| 02/15/2023 | 98.86% | Barclays | → $150 | Initiates Coverage On | → Overweight |
| 02/07/2023 | 82.95% | Citigroup | $126 → $138 | Maintains | Buy |
| 02/06/2023 | 52.46% | Wells Fargo | $104 → $115 | Maintains | Equal-Weight |
| 02/03/2023 | 77.65% | Cowen & Co. | $122 → $134 | Maintains | Outperform |
| 02/03/2023 | 101.51% | Oppenheimer | $159 → $152 | Maintains | Outperform |
| 02/03/2023 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
| 02/03/2023 | 78.97% | Raymond James | $125 → $135 | Maintains | Outperform |
| 01/17/2023 | 37.88% | Wells Fargo | $94 → $104 | Maintains | Equal-Weight |
| 01/09/2023 | 59.09% | B of A Securities | $151 → $120 | Downgrades | Buy → Neutral |
| 12/15/2022 | 52.46% | RBC Capital | $120 → $115 | Maintains | Outperform |
| 11/28/2022 | 39.2% | Morgan Stanley | $120 → $105 | Downgrades | Overweight → Equal-Weight |
| 11/04/2022 | 59.09% | RBC Capital | $125 → $120 | Maintains | Outperform |
| 11/04/2022 | 65.72% | Raymond James | $145 → $125 | Maintains | Outperform |
| 09/28/2022 | 69.69% | Citigroup | $150 → $128 | Maintains | Buy |
| 09/28/2022 | 72.35% | Berenberg | → $130 | Assumes | → Buy |
| 09/09/2022 | 109.47% | B of A Securities | $165 → $158 | Maintains | Buy |
| 08/11/2022 | 59.09% | Morgan Stanley | $149 → $120 | Maintains | Overweight |
| 08/08/2022 | 114.77% | Oppenheimer | $172 → $162 | Maintains | Outperform |
| 08/05/2022 | 75% | Deutsche Bank | $136 → $132 | Maintains | Buy |
| 08/05/2022 | 92.23% | Raymond James | $158 → $145 | Maintains | Outperform |
| 07/20/2022 | 129.35% | Guggenheim | $180 → $173 | Maintains | Buy |
| 07/18/2022 | 80.3% | Deutsche Bank | $137 → $136 | Maintains | Buy |
| 07/14/2022 | 97.53% | Morgan Stanley | $155 → $149 | Maintains | Overweight |
| 07/11/2022 | 35.22% | Wells Fargo | $112 → $102 | Maintains | Equal-Weight |
| 06/02/2022 | 105.49% | Morgan Stanley | $170 → $155 | Maintains | Overweight |
| 06/01/2022 | 78.97% | Goldman Sachs | $150 → $135 | Maintains | Buy |
| 05/09/2022 | 81.63% | Deutsche Bank | $140 → $137 | Maintains | Buy |
| 05/06/2022 | 98.86% | Credit Suisse | $160 → $150 | Maintains | Outperform |
| 05/06/2022 | 109.47% | Raymond James | $215 → $158 | Maintains | Outperform |
| 04/21/2022 | 85.6% | Deutsche Bank | $158 → $140 | Maintains | Buy |
| 04/18/2022 | 19.32% | Piper Sandler | $177 → $90 | Downgrades | Neutral → Underweight |
| 04/12/2022 | 48.48% | Wells Fargo | $108 → $112 | Upgrades | Underweight → Equal-Weight |
| 04/07/2022 | 112.12% | Barclays | $184 → $160 | Maintains | Overweight |
| 04/06/2022 | 125.37% | Morgan Stanley | $200 → $170 | Maintains | Overweight |
| 04/06/2022 | 118.75% | B of A Securities | → $165 | Upgrades | Underperform → Buy |
| 04/01/2022 | 43.18% | Wells Fargo | $114 → $108 | Maintains | Underweight |
| 03/22/2022 | 114.77% | Goldman Sachs | $189 → $162 | Maintains | Buy |
| 02/07/2022 | 165.15% | Morgan Stanley | $217 → $200 | Maintains | Overweight |
| 02/07/2022 | 145.26% | Credit Suisse | $190 → $185 | Maintains | Outperform |
| 12/16/2021 | 165.15% | Barclays | $212 → $200 | Maintains | Overweight |
| 11/11/2021 | 165.15% | Credit Suisse | $185 → $200 | Maintains | Outperform |
| 11/08/2021 | — | Piper Sandler | Downgrades | Overweight → Neutral | |
| 11/05/2021 | 185.03% | Raymond James | $200 → $215 | Maintains | Outperform |
| 11/05/2021 | 181.06% | Barclays | $186 → $212 | Maintains | Overweight |
| 11/05/2021 | 159.84% | Oppenheimer | $182 → $196 | Maintains | Outperform |
| 11/05/2021 | 154.54% | Goldman Sachs | $174 → $192 | Maintains | Buy |
| 11/05/2021 | 165.15% | RBC Capital | $176 → $200 | Maintains | Outperform |
| 10/11/2021 | 146.59% | Barclays | $174 → $186 | Maintains | Overweight |
| 10/07/2021 | 187.68% | Morgan Stanley | $210 → $217 | Maintains | Overweight |
| 10/05/2021 | 48.48% | Wells Fargo | $124 → $112 | Maintains | Underweight |
| 09/27/2021 | 130.68% | Goldman Sachs | $176 → $174 | Maintains | Buy |
| 09/20/2021 | 143.93% | Jefferies | $190 → $184 | Maintains | Buy |
| 09/10/2021 | 64.39% | Wells Fargo | $125 → $124 | Maintains | Underweight |
| 08/10/2021 | 178.4% | Morgan Stanley | $205 → $210 | Maintains | Overweight |
| 08/06/2021 | 137.31% | Oppenheimer | $171 → $179 | Maintains | Outperform |
| 08/06/2021 | 130.68% | Barclays | $164 → $174 | Maintains | Overweight |
| 08/06/2021 | 133.33% | Deutsche Bank | $169 → $176 | Maintains | Buy |
| 07/15/2021 | 124.05% | Deutsche Bank | $165 → $169 | Maintains | Buy |
| 07/09/2021 | 141.28% | Jefferies | $170 → $182 | Maintains | Buy |
| 07/07/2021 | 117.42% | Barclays | $161 → $164 | Maintains | Overweight |
| 06/24/2021 | 143.93% | Guggenheim | → $184 | Upgrades | Neutral → Buy |
| 05/13/2021 | 171.78% | Morgan Stanley | $200 → $205 | Maintains | Overweight |
| 05/10/2021 | 118.75% | Deutsche Bank | $162 → $165 | Maintains | Buy |
| 05/10/2021 | 165.15% | Raymond James | $160 → $200 | Maintains | Outperform |
| 03/26/2021 | 57.76% | Wells Fargo | → $119 | Initiates Coverage On | → Underweight |
| 03/25/2021 | 130.68% | RBC Capital | $168 → $174 | Maintains | Outperform |
| 03/01/2021 | 138.63% | Piper Sandler | $110 → $180 | Maintains | Overweight |
| 02/04/2021 | 112.12% | Raymond James | $109 → $160 | Maintains | Outperform |
| 02/04/2021 | 118.75% | Credit Suisse | $137 → $165 | Maintains | Outperform |
| 02/04/2021 | 165.15% | Morgan Stanley | $160 → $200 | Maintains | Overweight |
| 01/22/2021 | 77.65% | JP Morgan | $110 → $134 | Downgrades | Overweight → Neutral |
| 12/16/2020 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 11/17/2020 | — | B of A Securities | Downgrades | Buy → Underperform | |
| 11/02/2020 | 112.12% | Morgan Stanley | $150 → $160 | Maintains | Overweight |
| 11/02/2020 | — | Benchmark | Downgrades | Buy → Hold | |
| 10/30/2020 | 44.5% | Raymond James | $85 → $109 | Maintains | Outperform |
| 10/20/2020 | 55.11% | Baird | → $117 | Reinstates | → Outperform |
| 10/15/2020 | 45.83% | B of A Securities | $95 → $110 | Maintains | Buy |
| 10/15/2020 | 49.81% | Jefferies | $96 → $113 | Maintains | Buy |
| 10/06/2020 | 52.46% | Berenberg | → $115 | Initiates Coverage On | → Buy |
| 10/06/2020 | 41.85% | Keybanc | $90 → $107 | Maintains | Overweight |
| 09/18/2020 | 98.86% | Morgan Stanley | $63 → $150 | Maintains | Overweight |
| 09/08/2020 | 45.83% | Evercore ISI Group | → $110 | Upgrades | In-Line → Outperform |
| 08/04/2020 | 20.64% | Credit Suisse | $88 → $91 | Maintains | Outperform |
| 06/24/2020 | -16.48% | Morgan Stanley | $58 → $63 | Maintains | Overweight |
| 05/19/2020 | 14.01% | UBS | $50 → $86 | Upgrades | Neutral → Buy |
| 05/18/2020 | -23.11% | Morgan Stanley | $57 → $58 | Maintains | Overweight |
| 05/07/2020 | -0.57% | Deutsche Bank | $59 → $75 | Maintains | Buy |
| 05/06/2020 | 4.73% | Jefferies | $73 → $79 | Maintains | Buy |
| 05/06/2020 | -3.22% | JP Morgan | $68 → $73 | Maintains | Overweight |
| 05/06/2020 | 6.06% | Credit Suisse | $75 → $80 | Maintains | Outperform |
| 04/21/2020 | — | Guggenheim | Downgrades | Buy → Neutral | |
| 04/15/2020 | -7.2% | Goldman Sachs | → $70 | Initiates Coverage On | → Buy |
| 04/14/2020 | 16.66% | Piper Sandler | $108 → $88 | Maintains | Overweight |
| 04/13/2020 | 2.08% | Keybanc | $70 → $77 | Maintains | Overweight |
| 04/09/2020 | -16.48% | Oppenheimer | $98 → $63 | Maintains | Outperform |
| 04/02/2020 | -11.18% | Citigroup | → $67 | Reinstates | → Buy |
| 03/30/2020 | -24.43% | Morgan Stanley | $60 → $57 | Upgrades | Equal-Weight → Overweight |
| 03/25/2020 | 19.32% | Benchmark | $105 → $90 | Maintains | Buy |
| 03/24/2020 | -7.2% | Keybanc | $100 → $70 | Maintains | Overweight |
| 03/16/2020 | -20.46% | Morgan Stanley | $77 → $60 | Maintains | Underweight |
| 03/03/2020 | 19.32% | B of A Securities | $100 → $90 | Maintains | Neutral |
| 01/31/2020 | 39.2% | RBC Capital | $110 → $105 | Maintains | Outperform |
| 01/31/2020 | 45.83% | Baird | $105 → $110 | Maintains | Outperform |
| 01/31/2020 | 27.27% | Credit Suisse | $98 → $96 | Maintains | Outperform |
| 12/03/2019 | 51.13% | Piper Sandler | $81 → $114 | Upgrades | Neutral → Overweight |
| 10/31/2019 | 8.71% | Buckingham Research | $79 → $82 | Maintains | Neutral |
| 10/31/2019 | 36.55% | Baird | $100 → $103 | Maintains | Outperform |
| 10/16/2019 | 29.92% | Guggenheim | → $98 | Initiates Coverage On | → Buy |
| 09/25/2019 | -17.8% | Morgan Stanley | $63 → $62 | Maintains | Underweight |
| 09/13/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 09/12/2019 | 21.97% | UBS | $87 → $92 | Maintains | Neutral |
| 08/23/2019 | 15.34% | UBS | $81 → $87 | Maintains | Neutral |
| 08/01/2019 | 21.97% | B of A Securities | $90 → $92 | Maintains | Buy |
| 08/01/2019 | 27.27% | Credit Suisse | $90 → $96 | Maintains | Outperform |
| 08/01/2019 | 4.73% | Buckingham Research | $76 → $79 | Maintains | Neutral |
| 08/01/2019 | 31.25% | Baird | $96 → $99 | Maintains | Outperform |
| 08/01/2019 | 28.6% | JP Morgan | $93 → $97 | Maintains | Overweight |
| 06/28/2019 | -13.83% | Morgan Stanley | $67 → $65 | Maintains | Underweight |
| 06/27/2019 | — | Credit Suisse | Initiates Coverage On | → Outperform | |
| 06/11/2019 | 44.5% | Baird | $103 → $109 | Maintains | Outperform |
| 05/16/2019 | -11.18% | Morgan Stanley | $69 → $67 | Maintains | Underweight |
| 05/07/2019 | 0.76% | Buckingham Research | $80 → $76 | Maintains | Neutral |
| 04/22/2019 | 39.2% | Keybanc | $95 → $105 | Maintains | Overweight |
| 04/15/2019 | -8.52% | Morgan Stanley | $70 → $69 | Maintains | Underweight |
| 03/28/2019 | 23.29% | Oppenheimer | → $93 | Initiates Coverage On | → Outperform |
| 03/18/2019 | — | Buckingham Research | Downgrades | Buy → Neutral | |
| 02/13/2019 | — | Goldman Sachs | Upgrades | Buy → Conviction Buy | |
| 01/25/2019 | 3.41% | Piper Sandler | $110 → $78 | Downgrades | Overweight → Neutral |
| 12/11/2018 | 25.94% | Keybanc | → $95 | Initiates Coverage On | → Overweight |
| 12/04/2018 | 32.57% | Jefferies | → $100 | Initiates Coverage On | → Buy |
| 11/14/2018 | -4.55% | Morgan Stanley | $81 → $72 | Maintains | Underweight |
What is the target price for Aptiv (APTV)?
The latest price target for Aptiv (NYSE: APTV) was reported by Morgan Stanley on November 14, 2023. The analyst firm set a price target for $90.00 expecting APTV to rise to within 12 months (a possible 19.32% upside). 47 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aptiv (APTV)?
The latest analyst rating for Aptiv (NYSE: APTV) was provided by Morgan Stanley, and Aptiv maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Aptiv (APTV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aptiv, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aptiv was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
Is the Analyst Rating Aptiv (APTV) correct?
While ratings are subjective and will change, the latest Aptiv (APTV) rating was a maintained with a price target of $100.00 to $90.00. The current price Aptiv (APTV) is trading at is $75.43, which is out of the analyst's predicted range.